
Moving to an updated measure of obesity that goes beyond body mass index (BMI) could save the NHS time and money through avoiding misdiagnosis, UK researchers have concluded.
Two separate studies have shown poor performance of BMI as an indicator of health across adults in the UK and internationally.
It follows a Lancet Commission on Clinical Obesity report last year which urged doctors radically overhaul how they measure obesity, taking into account other measures such as body fat which better indicate risks of ill health.
One study published in Nature analysed health data from 844,108 adults in China, the UK, US and Spain and found that BMI alone missed obesity-level body fat in up to 8.6% of participants and inadequately classifying up to 3.1% of people.
Looking at longer-term health outcomes, obesity was linked to a higher risk of death only when identified using waist measurements alongside BMI, the team from King’s College London reported.
A separate study from researchers at University College London found that two thirds of people classified as living with obesity according to a BMI cut-off of >30kg/m2, would not be considered to have clinical obesity by the new definition.
Using data from the 1970 British Cohort Study on almost 7,000 46-year-olds, they also found a smaller number (4%) who were considered a healthy weight by BMI thresholds showed signs of having clinical obesity.
The new framework classified 30% of study participants as not having obesity, 53% as having a pre-clinical level of obesity and 18% as having clinical obesity.
By comparison, BMI classified 29% as of a healthy weight, 38% as overweight and 32% as having obesity.
Writing in the International Journal of Obesity, the team said this was the first study to look at the new definition of obesity in a wide found of people of a specific age.
They reiterated calls for clinicians and policymakers to consider ‘moving beyond BMI alone’ when it comes to assessing the health implications of an individual’s weight.
If the newer definition of obesity to used routinely by GPs and hospital doctors alongside BMI, the NHS could save time and money and may also better identify those people at greater risk of obesity-related illness in the future, they concluded.
Dr Jo Blodgett, a senior research fellow at University College London, and study lead said: ‘Midlife is a sensitive period when we consider trajectories of developing negative health outcomes.
‘Using the newer Lancet classification in this age group may help identify those at greatest risk of poor health and who would benefit most from intervention.
‘This has a lot of value from a policymakers’ perspective and could save the NHS and its staff time and money.’
Professor Francesco Rubino, chair of Metabolic and Bariatric Surgery at King’s College London, and senior author as well as being the chair of the Lancet Commission said: ‘Body mass index alone cannot tell us whether someone is already ill or at risk of illness, or what care they need, leaving people vulnerable to both undertreatment and overtreatment.
‘The new definition makes personalised, proportionate care possible whereas a uniform BMI-based definition prevents it.’
Dr Marie Spreckley, researchers in the Institute of Metabolic Science at the University of Cambridge, said the study provided important evidence for moving beyond BMI.
‘The findings suggest that BMI alone does not adequately capture differences in health risk, and that incorporating measures of abdominal adiposity and organ function provides a more informative assessment.’